Annual FCF:
-$229.81M-$58.82M(-34.40%)Summary
- As of today, CRNX annual free cash flow is -$229.81 million, with the most recent change of -$58.82 million (-34.40%) on December 31, 2024.
- During the last 3 years, CRNX annual free cash flow has fallen by -$140.79 million (-158.15%).
- CRNX annual free cash flow is now -3961.75% below its all-time high of -$5.66 million, reached on December 31, 2016.
Performance
CRNX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly FCF:
-$111.58M-$22.53M(-25.30%)Summary
- As of today, CRNX quarterly free cash flow is -$111.58 million, with the most recent change of -$22.53 million (-25.30%) on September 30, 2025.
- Over the past year, CRNX quarterly free cash flow has dropped by -$48.23 million (-76.13%).
- CRNX quarterly free cash flow is now -4656.22% below its all-time high of -$2.35 million, reached on March 31, 2017.
Performance
CRNX Quarterly Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$356.03M-$48.23M(-15.67%)Summary
- As of today, CRNX TTM free cash flow is -$356.03 million, with the most recent change of -$48.23 million (-15.67%) on September 30, 2025.
- Over the past year, CRNX TTM free cash flow has dropped by -$152.47 million (-74.90%).
- CRNX TTM free cash flow is now -15075.96% below its all-time high of -$2.35 million, reached on March 31, 2017.
Performance
CRNX TTM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
CRNX Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -34.4% | -76.1% | -74.9% |
| 3Y3 Years | -158.2% | -184.9% | -241.4% |
| 5Y5 Years | -390.3% | -516.4% | -496.0% |
CRNX Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -158.2% | at low | -214.5% | at low | -241.4% | at low |
| 5Y | 5-Year | -390.3% | at low | -718.6% | at low | -496.0% | at low |
| All-Time | All-Time | -3961.8% | at low | -4656.2% | at low | >-9999.0% | at low |
CRNX Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$111.58M(-25.3%) | -$356.03M(-15.7%) |
| Jun 2025 | - | -$89.05M(+0.7%) | -$307.80M(-16.0%) |
| Mar 2025 | - | -$89.69M(-36.5%) | -$265.32M(-15.4%) |
| Dec 2024 | -$229.81M(-34.4%) | -$65.70M(-3.7%) | -$229.81M(-12.9%) |
| Sep 2024 | - | -$63.35M(-36.0%) | -$203.56M(-10.0%) |
| Jun 2024 | - | -$46.57M(+14.1%) | -$185.05M(-0.3%) |
| Mar 2024 | - | -$54.19M(-37.4%) | -$184.45M(-7.9%) |
| Dec 2023 | -$171.00M(-46.3%) | -$39.45M(+12.0%) | -$171.00M(-2.4%) |
| Sep 2023 | - | -$44.84M(+2.5%) | -$167.03M(-3.5%) |
| Jun 2023 | - | -$45.97M(-12.9%) | -$161.35M(-12.1%) |
| Mar 2023 | - | -$40.73M(-14.8%) | -$143.97M(-23.2%) |
| Dec 2022 | -$116.86M(-31.3%) | -$35.48M(+9.4%) | -$116.86M(-12.0%) |
| Sep 2022 | - | -$39.16M(-37.0%) | -$104.30M(-14.7%) |
| Jun 2022 | - | -$28.59M(-109.8%) | -$90.95M(-10.3%) |
| Mar 2022 | - | -$13.63M(+40.5%) | -$82.47M(+7.4%) |
| Dec 2021 | -$89.02M | -$22.92M(+11.2%) | -$89.02M(-8.5%) |
| Sep 2021 | - | -$25.81M(-28.4%) | -$82.06M(-10.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$20.11M(+0.4%) | -$74.35M(-6.1%) |
| Mar 2021 | - | -$20.18M(-26.5%) | -$70.11M(-12.7%) |
| Dec 2020 | -$62.21M(-32.7%) | -$15.96M(+11.9%) | -$62.21M(-4.2%) |
| Sep 2020 | - | -$18.10M(-14.1%) | -$59.73M(-8.1%) |
| Jun 2020 | - | -$15.87M(-29.1%) | -$55.24M(-6.2%) |
| Mar 2020 | - | -$12.29M(+8.8%) | -$52.00M(-10.9%) |
| Dec 2019 | -$46.87M(-128.4%) | -$13.47M(+1.0%) | -$46.87M(-18.1%) |
| Sep 2019 | - | -$13.61M(-7.8%) | -$39.69M(-23.9%) |
| Jun 2019 | - | -$12.62M(-76.1%) | -$32.03M(-32.2%) |
| Mar 2019 | - | -$7.17M(-13.9%) | -$24.22M(-18.0%) |
| Dec 2018 | -$20.52M(-109.7%) | -$6.29M(-5.8%) | -$20.52M(-20.9%) |
| Sep 2018 | - | -$5.94M(-23.3%) | -$16.97M(-25.8%) |
| Jun 2018 | - | -$4.82M(-39.1%) | -$13.49M(-55.6%) |
| Mar 2018 | - | -$3.46M(-26.3%) | -$8.67M(-14.8%) |
| Dec 2017 | -$9.78M(-72.9%) | -$2.74M(-11.4%) | -$7.55M(-57.0%) |
| Sep 2017 | - | -$2.46M(-4.9%) | -$4.81M(-104.9%) |
| Mar 2017 | - | -$2.35M | -$2.35M |
| Dec 2016 | -$5.66M | - | - |
FAQ
- What is Crinetics Pharmaceuticals, Inc. annual free cash flow?
- What is the all-time high annual free cash flow for Crinetics Pharmaceuticals, Inc.?
- What is Crinetics Pharmaceuticals, Inc. annual free cash flow year-on-year change?
- What is Crinetics Pharmaceuticals, Inc. quarterly free cash flow?
- What is the all-time high quarterly free cash flow for Crinetics Pharmaceuticals, Inc.?
- What is Crinetics Pharmaceuticals, Inc. quarterly free cash flow year-on-year change?
- What is Crinetics Pharmaceuticals, Inc. TTM free cash flow?
- What is the all-time high TTM free cash flow for Crinetics Pharmaceuticals, Inc.?
- What is Crinetics Pharmaceuticals, Inc. TTM free cash flow year-on-year change?
What is Crinetics Pharmaceuticals, Inc. annual free cash flow?
The current annual free cash flow of CRNX is -$229.81M
What is the all-time high annual free cash flow for Crinetics Pharmaceuticals, Inc.?
Crinetics Pharmaceuticals, Inc. all-time high annual free cash flow is -$5.66M
What is Crinetics Pharmaceuticals, Inc. annual free cash flow year-on-year change?
Over the past year, CRNX annual free cash flow has changed by -$58.82M (-34.40%)
What is Crinetics Pharmaceuticals, Inc. quarterly free cash flow?
The current quarterly free cash flow of CRNX is -$111.58M
What is the all-time high quarterly free cash flow for Crinetics Pharmaceuticals, Inc.?
Crinetics Pharmaceuticals, Inc. all-time high quarterly free cash flow is -$2.35M
What is Crinetics Pharmaceuticals, Inc. quarterly free cash flow year-on-year change?
Over the past year, CRNX quarterly free cash flow has changed by -$48.23M (-76.13%)
What is Crinetics Pharmaceuticals, Inc. TTM free cash flow?
The current TTM free cash flow of CRNX is -$356.03M
What is the all-time high TTM free cash flow for Crinetics Pharmaceuticals, Inc.?
Crinetics Pharmaceuticals, Inc. all-time high TTM free cash flow is -$2.35M
What is Crinetics Pharmaceuticals, Inc. TTM free cash flow year-on-year change?
Over the past year, CRNX TTM free cash flow has changed by -$152.47M (-74.90%)